Trastuzumab Rezetecan in EBBR2-Low Metastatic Breast Cancer

Corresponding Author: Fabrice André, MD, PhD, Gustave Roussy, Université Paris-Saclay, Department of Medical Oncology, INSERM U981, 114 rue Edouard Vaillant, F-94805 Villejuif, France (f.andre@gustaveroussy.fr).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.